🔗 Share this article

Chancellor Reeves has stated she is preparing "targeted action to address cost of living issues" in the forthcoming Budget.

Speaking to media outlets, she emphasized that curbing price rises is a shared duty of both the government and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Bill Interventions

Sources suggest the government could intervene to bring down energy bills, for instance by reducing the current 5% level of VAT applied on energy.

An additional possibility is to reduce some of the regulatory levies presently included in bills.

Budgetary Constraints and Analyst Expectations

The administration will obtain the next assessment from the official forecaster, the OBR, on the start of the week, which will reveal how much scope there is for such measures.

The consensus from the majority of economists is that Reeves will have to announce higher taxes or spending cuts in order to adhere to her declared fiscal targets.

Previously on Thursday, analysis indicated there was a £22bn gap for the chancellor to resolve, which is at the lower end of expectations.

"There's a collective task between the central bank and the government to further reduce some of the drivers of inflation," Reeves told the BBC in the US capital, at the conferences of the IMF and global financial institution.

Tax Pledges and International Concerns

While a great deal of the focus has been on probable tax rises, the chancellor said the latest data from the fiscal watchdog had not changed her commitment to manifesto promises not to increase rates on income tax, VAT or social security contributions.

She blamed an "unpredictable global environment" with growing geopolitical and trade tensions for the fiscal tax moves, probably to be targeted on those "wealthiest."

International Trade Disputes

Addressing worries about the UK's economic relations with China she said: "The UK's security interests invariably take priority."

Last week's statement by China to tighten trade restrictions on rare earths and other resources that are crucial for advanced tech production led American leader Donald Trump to threaten an extra 100% import tax on imports from the Asian country, raising the possibility of an all-out trade war between the two largest economies.

The US Treasury Secretary called China's move "economic coercion" and "a international production control attempt."

Questioned on considering the US offer to participate in its conflict with China, Reeves said she was "extremely troubled" by China's measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "bad for the world economy and causes further headwinds."

"It is my opinion there are fields where we should confront China, but there are also significant chances to sell into Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that balance correct."

The Treasury chief also affirmed she was collaborating with other major economies "on our own essential resources plan, so that we are reduced dependence."

NHS Medicine Costs and Funding

Reeves also acknowledged that the cost the National Health Service pays for medicines could increase as a result of ongoing negotiations with the US government and its drugs companies, in return for reduced taxes and capital.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either pausing or canceling operations in the United Kingdom, with some attributing the low prices they are receiving.

Last month, the Science Minister said the cost the NHS spends on medicines would have to rise to prevent businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor informed the BBC: "It has been observed because of the pricing regime, that clinical trials, new drugs have not been provided in the United Kingdom in the manner that they are in other European countries."

"We want to ensure that individuals getting care from the NHS are able to access the best critical drugs in the globe. And so we are examining these issues, and... seeking to obtain increased investment into Britain."